Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
71	[KR] Composition for treating stroke and method for screening the same (Registration number 10-2337954)
70	[KR] Differentiation induction culture medium for pluripotent stem cells derived MSCs, method for producing MSCs and MSCs produced using the same (Registration number 10-2325449)
69	[EA] Method and Composition for Proliferating of Natural Killer Cell (Registration number 38848)
68	[RU] Stem cell-derived epidermal progenitor cell conditioned medium and method for production thereof (Registration number 2754043)
67	[JP] Enhanced umbilical cord adherent stem cells, method for producing and uses thereof (Registration number 6921249)
66	[EP] Method for proliferating neuronal progenitor cells and composition for treating nervous diseases comprising the neuronal progenitor cells (Registration number 3205717)
65	[KR] Method for inducing differentiation of human embryonic stem cells into mesodermal lineage cells (Registration number 10-2249930)
64	[KR] Enhanced postnatal adherent cells and method for producing the same (Registration number 10-2128224)
63	[JP] A method for preserving of Nuclear Transfer Cells and banking system thereof (Registration number 06707636)
62	[KR] Stem cell-derived epidermal progenitor cell conditioned medium and method for production thereof (Registration number 10-2100608)